EPA Position Paper on Psychiatric Care of Refugees in Europe
The European Psychiatric Association (EPA) is strongly concerned by the impact of the current refugee migration crisis on mental health care in Europe. As recent developments have made the situation particularly challenging for the healthcare systems in the different EU Member States. As for mental health in particular, most services have been coping with an increasing demand related to psychiatric illnesses, limited healthcare resources, decreasing numbers of trained specialists and new legal requirements.
Within this context, EPA has sent the European Commission and its National Societies/Associations an EPA Position statement on Psychiatric Care of Refugees in Europe, aiming to increase attention to the importance of appropriate and timely provision of mental health care to refugees and migrants in Europe.
Support of the DGPPN Statement on the crash of flight 4U9525
The German Association for Psychiatry, Psychotherapy and Psychosomatics (DGPPN), Professional Association of German Specialists for Neurology and Psychiatry (BVDN) and Professional Association of German Specialists in Psychiatry and Psychotherapy (BVDP) wrote a joint statement about the crash of Germanwings flight 4U9525. The European Psychiatric Association (EPA) fully supports this statement and its dissemination to counteract increasing stigma of people with mental diseases.
EPA Position Statement 2015
The UN Commission on Narcotic Drugs, 58th Session, was asked to review a proposal to place ketamine in Schedule I of the 1971 Convention (E/CN.7/2015/7 and E/CN.7/2015/8). A wide range of national and international civil society organisations, including medical associations, have voiced concern about the proposal and endorsed the Fact Sheet on the Proposal to Discuss International Scheduling of Ketamine at the 58th CND. To support the fact sheet and raise awareness, EPA wrote the EPA Position Statement on Ketamine in Psychiatric treatment and research.
EPA Position Statement 2009
In 2009 EPA published a practical guidance on the prevention of Cardiovascular disease (CVD) and diabetes in people with severe mental illness (SMI)* (European Psychiatry Journal Vol 24 - N° 6 - September 2009), in consultation with and supported by the European Society of Cardiology (ESC) and the European Association for the Study of Diabetes (EASD). This joint position statement is designed to show how current European CVD prevention and diabetes guidelines can be optimally applied to patients with SMI, and how psychiatrists can incorporate cardiovascular risk assessment into their daily practice.
The position statement has been translated into several European languages: